About Biomeme
Real-time PCR anywhere you need it.
Marc DeJohn, Jesse vanWestrienen, and Max Perelman founded Biomeme with the vision of enabling anyone, anywhere, to explore the biological world.
Biomeme started out by creating the first iPhone add-on capable of performing molecular diagnostics. Since our inception, we have used advanced biology and chemistry along with world-class hardware and software engineering to create elegant solutions to complex problems. Over the years our team has grown, and along the way Biomeme has built the leading mobile molecular diagnostics platform.
Facts about Biomeme
Facts about Biomeme
- Founding: 2012
- Focus : Manufacturer
- Employees: 51-200
- Industry : Laboratory equipment / supplies
Here you will find Biomeme Inc.
Last viewed contents
Methicillin
Methylphenidate
Medtech company Theraclion obtains €8.5 million in R&D funding from OSEO
Amgen Announces the Formation of Amgen Ventures - Venture Capital Fund Designed to Provide Resources to Help Advance Early-Stage Biotechnology Companies and Human Therapeutics
Direvo and Danisco Collaboration Yields New Industrial Enzyme
Clavis Pharma receives USD 1.1 million Grant to Accelerate the Phase II Programme of Intravenous CP-4126 in Pancreatic Cancer
PIER-ELECTRONIC GmbH - Hofheim am Taunus, Germany
Pharma. Direct Ltd - Bedford, United Kingdom
Forum Verlag Herkert GmbH - Merching, Germany
Cognis licenses further active ingredients for weight management and heart health from InterMed Discovery
Mirus Bio Corporation - Madison, USA
